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ABSTRACT
Bis-symmetrical tripropoxy p-tert-butyl calix[4]arene esters were prepared from the reaction of tripropoxy calix[4]arene (1HPr3)
with di-acyl chlorides as bridges in the presence of sodium hydride. The esters, which were synthesized from L-alanine acyl
chloride derivatives, are optically active. In all of these esters, calix[4]arene cavities have a pinched cone conformation. The
structures of these esters were confirmed by FT-IR, 1H NMR and 13C NMR spectroscopy, elemental analysis and ion positive FAB
mass spectrometry.
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1. Introduction
Calixarenes, which are phenol-formaldehyde cyclic oligomers,
are receiving increasing attention in the field of supramolecular
chemistry. Calix[4]arenes can be selectively functionalized
easily, both at the phenolic OH groups (lower rim)1 and at the
para positions of the phenol rings (upper rim). Consequently
they are useful building blocks for host molecules with different
properties.2,3 It was recognized by Cornforth4 that a calix[4]arene
can exist in four main conformations. The first bis-calix[4]arenes
connected via a single bridge between the narrow rims were
prepared by reacting the triester monoacid chloride with
1,2-diaminoethane or ethylene glycol in benzene. X-ray struc-
tural studies showed the usual pinched cone conformation of
the two calix[4]arene units.5
In this study, we report the synthesis of new calix[4]arene
esters by the reaction of tripropoxy calix[4]arene (1HPr3) with
acyl chloride bridges (Table 1) in the presence of NaH as base
(Scheme 1). One of them is a type of mono-optically active ester
(phthaloyl-L-alanine ester of 1HPr3) and it adopts a pinched
cone conformation. The others are double calix[4]arenes with
symmetrical structures and cone conformations (Table 2). Many
calixarene derivatives have been incorporated as neutral
ionophores into ion-selective electrodes for alkali metal ions.6,7
This property was used successfully for the analysis of Na+ in
blood using both steady-state and flow-injection analysis (FIA)
techniques8–10 and plays a critical role in maintaining homeosta-
sis in metabolism.11
To date, various calixarenes that possess ester,12 amide13 or
other functional groups have been synthesized for separation,14
recognition,15 discrimination16 and catalysis.17 Among them,
chiral recognition18 is one of the more essential reaction processes
occurring in living systems. Among the most popular chiral
building blocks used, amino acids19 offer a wide range of possi-
bilities for providing calix[4]arenes with asymmetric features.
Many of the chiral calix[4]arene derivatives have shown remark-
able recognition properties toward achiral cations and anions;20
however, more interestingly, some of them have exhibited
significant chiral discrimination abilities for chiral guests such as
amino acids.21
2. Results and Discussion
Four different conformers for calix[4]arenes exist. These
conformations are driven by substitution of the four bulky sub-
stituents at the phenolic oxygen atoms and the conformations
are named cone, partial cone, 1,2-alternate and 1,3-alternate.
The structures of these conformers can be easily distinguished
by their characteristic 1H NMR patterns arising from the
ArCH2Ar methylene protons. The splitting patterns for ArCH2Ar
protons of these four conformers are: a pair of doublets for cone,
two pairs of doublets for partial cone, one singlet and a pair of
doublets for 1,2-alternate and one singlet for 1,3-alternate.22–24
The conformations of calix[4]arenes can be deduced from the
13C NMR chemical shifts of the methylene groups connecting
each pair of aromatic rings.25 When the phenol rings adjacent to
each methylene are in a syn orientation (in cone conformations),
the methylene signals appear around δ 31 ppm, whereas they
appear around δ 37 ppm when both phenol rings are anti oriented
(in 1,3-alternate conformations). However, an inspection of the
proton-decoupled l3C NMR spectra of all the series revealed that
the methylene carbon chemical shift always ranged around two
values: δ 31 and 37 ppm. In cone conformations, adjacent phenol
rings are in a syn orientation only (δ 31 ppm); while in the other
conformations, adjacent phenol rings are in both syn and anti
orientations.
Compound 2 (1HPr3)has only one hydroxyl group in the lower
rim, therefore its reactions with acyl halides are more selective
and do not produce any other by-products. Because of the lower
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acidity of the proton of the OH group in compound 2, it was
activated by using NaH as a strong base; also the small size of
NaH is very useful for this type of reaction. All of the esters are
soluble in low polarity solvents such as CH2Cl2 and CHCl3, but
they are insoluble in polar solvents such as DMSO, DMF, MeOH
and H2O. This phenomenon is attributed to the existence of the
bulky non-polar moiety in their structures, so they are categorized
as non-polar molecules.
The splitting pattern for ArCH2Ar protons (a pair of doublets
with a typical AX pattern) shows that the compounds 5c
(terephthaloyl diester of 1HPr3) and 5d (adipoyl diester of
1HPr3) adopt a cone conformation. We used the DEPT-135 tech-
nique to distinguish signals relevant to methylene carbons in the
products. The compound 5c DEPT-135 spectrum has two signals
relevant to the methylene carbons that are contracted together
at δ 30.96 ppm. This confirms that 5c adopts a cone conforma-
tion. The compound 5d DEPT-135 spectrum has one signal rele-
vant to the methylene carbons at δ 30.71 ppm. This confirms that
5d adopts a cone conformation. There is a signal at δ 33.63 ppm in
the DEPT-135 spectrum of compound 5d which is relevant to
the compound 4d (adipoyl chloride) methylene carbons. The
conformation recognition of 5a (phthaloyl-L-alanine ester of
1HPr3) via the
1H NMR spectrum is difficult; but the DEPT-135
spectrum does not show a signal at δ 37 ppm; it has three signals
in the range δ 30.8, 31.2 and 31.36 ppm. These results show that
the compound adopts a pinched cone conformation and the
symmetry in this molecule is low. There is a signal at δ 30.28 ppm
in this spectrum which is relevant to CH2*-CH3 carbon(s) in
propyl group(s). Similar to compound 5a, the characterization
of 5b (diimido-di-L-alanine diester of 1HPr3) via the
1H NMR
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Table 1 Esterification conditions and yields.
Compound no. Structure of bridging sample Molar ratio of NaH to 4a–d Reaction time/h Product name Yield/%
4a 2 5 5a 28
4b 7.5 5 5b 23
4c 7.5 4 5c 53
4d 6 4 5d 56
Scheme 1
General synthetic pathway for synthesis of double calix[4]arenes.
spectrum is also difficult, but in its DEPT-135 spectrum, there is
no signal in the region δ 37 ppm, but it has three signals at δ 30.72,
31.2 and 31.31 ppm. These results show that it adopts a pinched
cone conformation. There is a signal at δ 30.54 ppm in this spectrum
which is relevant to CH2*-CH3 carbon(s) in the propyl group(s).
With comparison of the 1H NMR and l3C NMR spectra for
compounds 5a and 5b in the aliphatic and aromatic regions, we
realized that the symmetry in 5b is decreased toward 5a and
maximum similarity of these compounds is related to the
splitting pattern for ArCH2Ar protons (Table 3). In the synthesis
of 5a and 5b, we used L-alanine; therefore, both products are
optically active and can potentially exhibit importance in
pharmaceutical applications.26 When acyl chlorides were used in
the synthesis of more bulky 5a and 5b compounds, the yields of
these products were low. General results are summarized in
Table 1.
The extraction ability of a calixarene for neutral guests depends
on the size of the calixarene cavity and its conformation. A fixed
cone conformer is more effective for extraction of neutral guests
in solution. All of our novel products are fixed in the cone confor-
mation; therefore they should be suitable for extraction of
α-amino acids (e.g. alanine) from aqueous solution to the organic
phase. We performed the extraction of neutral guest experiments
only for D,L-alanine following Pedersen’s procedure.27 The
results of these experiments are summarized in Table 2. The
enantioselective recognition ability of the receptors was studied
by UV/visible absorption spectroscopy. All receptors efficiently
extracted D,L-alanine; however, whether chiral or achiral, they
did not show any enantioselectivity towards either alanine
enantiomer. The percentage extraction value (Ex %) for 5d is
higher than for the other compounds. This is attributed to the
size-fitting of 5d and alanine.
Solvent extraction of metal salts, mostly picrates, from water
into an organic solvent, usually CH2Cl2 or CHCl3 was performed
at 25 °C. The esters are suitable for encapsulating guest cations,
and excellent selectivity in favour of Na+ was obtained. The
results of the extraction ability of 5a–d for Na+ are summarized in
Table 2. Although the Na+ selectivity of ionophoric calix[4]arenes
can be changed by conformation, the Na+ affinity observed for
cone conformers is always the highest amongst all four possible
conformers.30 Amide and ester groups in calix[4]arenes possess a
high affinity for Na+, also double calix[4]arenes have two metal
complexing sites. The induced 3D cavity (size-fitting) of the
parent calixarene platform and the attached side arms upon
complexation play an important role in cation binding ability
and selectivity. The percentage extraction value for 5b is higher
than for the other compounds; this is attributed to the existence
of more donor carbonyl groups in 5b than in the others.
3. Experimental
3.1. General Procedure
Melting points of all compounds were recorded on Philip Harris
C4954718 apparatus (Birmingham, UK) without calibration.
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Table 2 Properties of final products.
Compound  no. M.p./°C Conformation Product type [α]D
20/deg cm² g–1 Optical activity Ex % of Na+Pic– Ex % of alanine
5a 239–40 pinched cone mono –17.3 active 24.2 19.2
5b >311 pinched cone bis –19.2 active 43.1 33.4
5c >309 cone bis 0 inactive 31.5 39.5
5d >314 cone bis 0 inactive 32.4 42.1
Table 3 Characteristic spectral data of final products.
Sample no. 1H NMR Splitting pattern 1H NMR ArCH2Ar Splitting pattern of J/Hz
13C NMR C=O 13C NMR FABMS a
ArH CDCl3 of ArH protons CDCl3 δ/ppm ArCH2Ar protons CDCl3 ArCH2Ar data/m e
-1
δ/ppm δ/ppm δ/ppm
5a 6.78–88 multiplet 3.15–3.19 doublet 12.6 167.81 30.80 976
7.73–75 multiplet 3.25–3.29 doublet 12.9 170.19 31.20




5b 6.74 singlet 3.16–3.20 doublet 12.3 169.95 30.72 1875
6.96 singlet 3.27–3.32 doublet 12.9 170.00 31.20




5c 6.86 singlet 3.16–3.21 doublet 12.6 166.38 30.96 1681
6.94 singlet 3.27–3.31 doublet 12.9 31.01
7.04 singlet 4.22–4.26 doublet 12.6
8.93 singlet 4.51–4.55 doublet 12.3
5d 6.49–50 doublet 3.17–3.21 doublet 12.3 174.48 30.71 1661
6.59–60 doublet 3.18–3.23 doublet 13.2
7.16–18 doublet 4.07–4.11 doublet 12.9
4.53–4.57 doublet 12.3
a 976 = (M+1)+; rest of numbers are equal to (M+2)+.
Optically active samples were analyzed by EHARTNACK appa-
ratus (Paris, France) at 20 °C with dichloromethane solvent. IR
spectra were determined on a Thermo Nicolet 610 Nexus FT-IR
spectrometer (Waltham, MA, USA) in KBr disks. Ultraviolet
spectra were recorded on a Shimadzu UV-2401/PC spectrometer
(Columbia, MD, USA). 1H (300 MHz) and 13C (75.5 MHz) NMR
measurements were recorded on a Bruker AVANCE 300 spec-
trometer (Ettlingen, Germany) in CDCl3 or CD3OD using TMS as
the internal reference. Elemental analyses were performed
using a Heraeus CHN-O-Rapido analyzer (Austin, TX, USA).
Positive ion FAB mass spectra were recorded using a JEOL
AX505HA spectrometer (Tokyo, Japan) and m-nitro benzyl
alcohol as matrix. Thin layer chromatography (TLC) analyses
were carried out on silica gel plates. All chemicals were purchased
from Merck (Tehran, Iran) and used as received by standard
procedures, such as difunctional reagent 4c (terephthaloyl chlo-
ride) and 4d (adipoyl chloride). All reactions were carried out
under a nitrogen or argon atmosphere. All of the instruments,
chemicals and solvents for esterification were dried according
to standard methods. Freshly distilled solvents were used
throughout, and anhydrous solvents were dried according to
Perrin and Armarego.28 THF was freshly distilled over sodium/
benzophenone ketyl.
3.1.1. p-tert-butyl calix[4]arene (1) was prepared according to
Gutsche’s method29 as white crystals.
3.1.2. The cone conformer of 25,26,27-tripropoxy-28-hydroxy-p-
tert-butyl calix[4]arene (2) was prepared by the previously re-
ported method30,31 as white crystals.
3.1.3. 2-(1,3-dioxoisoindolin-2-yl) propanoic acid (3a) was pre-
pared by the previously reported method32 as a white solid.
3.1.4. 2-(1,3-dioxoisoindolin-2-yl) propanoyl chloride (phthaloyl-
L-alanine chloride) (4a)
Compound 3a (1 g) was refluxed in SOCl2 (20 mL) for 12 h. The
solvent was evaporated. Then 2 drops of formic acid were added
to the residue and this was recrystallized from CH2Cl2/n-hexane
to give colourless crystals. This compound is very sensitive to
moisture; therefore, the melting point is not reported.
3.1.5. 2,2’-(1,3,5,7-tetraoxopyrrolo[3,4-f]isoindole-
2,6(1H,3H,5H,7H)-diyl) dipropanoic acid (N,N’-
pyromelliticdiimido-di-L-alanine chloride) (3b)
1,2,4,5-benzene-tetra carboxylic-1,2:4,5-dianhydride (2.18 g,
10 mmol) and L-alanine (1.78 g, 20 mmol) were refluxed in acetic
acid (50 mL) for 24 h. The solvent was evaporated. The residue
was recrystallized from H2O/MeOH to give a white solid.
3.1.6. 2,2’-(1,3,5,7-tetraoxopyrrolo[3,4-f]isoindole-
2,6(1H,3H,5H,7H)-diyl) dipropanoyl chloride (4b)
Compound 3b (1 g) was refluxed in a mixture of SOCl2 (15 mL)
and ethyl acetate (5 mL) for 12 h. The solvent was evaporated.
Then 2 drops of formic acid were added to the residue and this
was recrystallized from CH2Cl2/n-hexane to give colourless
crystals. This compound is very reactive and sensitive to mois-
ture; therefore, the melting point is not reported.
3.1.7. 25-[2-(1,3-dioxoisoindolin-2-yl)propanoate]-5,11,17,23-
tetra-tert-butyl-26,27,28-tripropoxy calix[4]arene (5a)
To a solution of 775 mg (1 mmol) of compound 2 and 18 mg
(3 mmol) NaH (60 % dispersion in oil) in THF (20 mL), 355 mg
(1.5 mmol) of compound 4a in THF (5 mL) was added at once
while stirring on an ice bath. The reaction mixture was stirred for
5 h at room temperature and the solvent was evaporated. The
residue was triturated with MeOH and recrystallized from




To a solution of 1.55 g (2 mmol) of compound 2 and 35 mg
(6 mmol) NaH (60 % dispersion in oil) in THF (20 mL), 395 mg
(1 mmol) of compound 4b in THF (5 mL) was added at once
while stirring on an ice bath. The reaction mixture was stirred for
5 h at room temperature and the solvent was evaporated. The
residue was triturated with MeOH and recrystallized from
CH2Cl2/MeOH to give a white powder.
3.1.9. Bis-[25-(5,11,17,23-tetra-tert-butyl-26,27,28-tripropoxy
calix[4]arene)] terephthalate (5c)
To a solution of 1.55 g (2 mmol) of compound 2 and 35 mg
(6 mmol) NaH (60 % dispersion in oil) in THF (20 mL), 162 mg
(0.8 mmol) of compound 4c in THF (5 mL) was added at once
while stirring on an ice bath. The reaction mixture was stirred for
4 h at room temperature and the solvent was evaporated. The
residue was triturated with MeOH and recrystallized from
CH2Cl2/MeOH to give a white powder.
3.1.10. Bis-[25-(5,11,17,23-tetra-tert-butyl-26,27,28-tripropoxy
calix[4]arene)] adipoyl dioate (5d)
To a solution of 1.55 g (2 mmol) of compound 2 and 35 mg
(6 mmol) NaH (60 % dispersion in oil) in THF (25 mL), 157 mg
(0.8 mmol) of compound 4d (liquid) was added at once while
stirring on an ice bath. The reaction mixture was stirred for 4 h at
room temperature and the solvent was evaporated. The residue
was triturated with MeOH and recrystallized from CH2Cl2/
MeOH to give a white powder.
3.2. Analytical Procedure (D,L-alanine Extraction)
To prepare the ammonium picrates, an aqueous solution of
alanine hydrochloride salt was treated with a saturated Na2CO3
solution and extracted three times with CH2Cl2. The organic
phase was then dried over MgSO4. The solvent was evaporated
to dryness to give the pure alanine. Then alanine and picric acid
in the molar ratio of 1:1 were dissolved in deionized water. The
stock solution was diluted to 2.0 × 10–5 mol L–1 and then used in
liquid–liquid extraction experiments. Picrate extraction experi-
ments were performed following Pedersen’s procedure:27 10 mL
of 2.0 × 10–5 mol L–1 aqueous picrate and 10 mL of 1.0 × 10–3 mol
L–1 solution of 5a–d in CH2Cl2 were vigorously agitated in a
stoppered glass tube with a mechanical shaker for 2 min, then
magnetically stirred in a thermostated water bath at 25 °C for 1 h,
and finally left to stand for an additional 30 min. Then the
concentration of picrate ion remaining in the aqueous phase was
determined spectrophotometrically at 357 nm. Blank experi-
ments showed that no picrate extraction occurred in the absence
of calixarene.
3.3. Analytical Procedure (Na+ Extraction)
The organic phase (5 mL of CH2Cl2) containing 5a–d
(2.50 mmol L–1) and aqueous phase (5 mL) containing Na+Pic–
(0.25 mmol L–1), NaOH (0.10 mol L–1) and NaCl (0.50 mol L–1) were
mixed and the mixture was shaken for 12 h at 25 °C. Extraction
percentage values were determined spectrophotometrically at
357 nm. Blank experiments showed that no picrate extraction
occurred in the absence of calixarene.
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Yield: 61 % (0.66 g). 1H NMR (CDCl3): δ 1.79–1.81 (d, 3H, J =
7.5 Hz, Me), 5.14–5.22 (q, 1H, J = 7.5 Hz), 7.79–7.82 (m, 2H, ArH)
and 7.92–7.95 ppm (m, 2H, ArH).
3.4.2. (3b)
Yield: 86 % (3.1 g). M.p. 280–282 °C. IR (KBr): ν = 3097, 3035,
1781, 1716, 1465, 1382 and 1258 cm–1. 1H NMR (CD3OD):
δ 1.70–1.73 (d, 6H, J = 7.5 Hz, Me), 5.01–5.08 (q, 2H, J = 7.5 Hz)
and 8.31 ppm (s, 2H, ArH). 13C NMR (CD3OD): δ 13.84, 22.83,
117.64, 137.19, 165.61 and 171.29 ppm.
3.4.3. (4b)
Yield: 92 % (1 g). 1H NMR (CDCl3): δ 1.85–1.88 (d, 6H, J = 7.5 Hz,
Me), 5.21–5.28 (q, 2H, J = 7.5 Hz) and 8.43 ppm (d, 2H, ArH).
3.4.4. (5a)
Yield: 28% (0.27 g). M.p. 239–240 °C. IR (KBr): ν = 2962, 2874,
1756, 1720, 1480, 1388 and 1196 cm–1. 1H NMR (CDCl3): δ 0.92–1.01
(m, 9H, CH2-CH3*), 1.05–1.07(d, 18H, J = 5.7 Hz, t-Bu), 1.1–1.15
(d, 18H, J = 14.4 Hz, t-Bu), 1.89–2.03 (m, 6H, CH2*-CH3), 2.31–2.33
(d, 3H, J = 7.5 Hz, CH-CH3*), 3.15–3.19 (d, 3H, Ar-CH2-Ar),
3.25–3.29 (d, 1H, Ar-CH2-Ar), 3.80–3.95 (m, 6H, OCH2), 3.96–4.01
(d, 1H, Ar-CH2-Ar), 4.27–4.31 (d, 1H, Ar-CH2-Ar), 4.46–4.53 (dd,
2H, Ar-CH2-Ar), 5.59–5.67 (q, 1H, J = 7.5 Hz, CH*-CH3), 6.78–6.88
(m, 8H, ArH), 7.73–7.75 (m, 2H, ArH) and 7.88–7.91 ppm (m, 2H,
ArH). 13C NMR (CDCl3): δ 10.03, 10.15, 10.21, 15.82, 23.09, 23.12,
30.28, 30.8, 31.2, 31.36, 31.39, 31.42, 31.51, 31.63, 33.84, 33.98, 49.22,
77.1, 77.27, 123.36, 124.78, 124.91, 125.03, 125.06, 125.2, 125.35,
125.42, 132.16, 132.97, 133.03, 133.25 133.55, 133.7, 133.8, 133.91,
134, 143.67, 144.37, 144.49, 144.54, 147.13, 152.82, 152.87, 153.77,
167.81 and 170.19 ppm. C64H81NO7 (975.60): calcd. C 78.73, H 8.36,
N 1.43 %; found C 78.81, H 8.29, N 1.44 %.
3.4.5. (5b)
Yield: 23% (0.43 g). Compound 5b decomposes above 311 °C
thus the melting point was not determined. IR (KBr): ν = 2962,
2875, 1759, 1719, 1481, 1386 and 1197 cm–1. 1H NMR (CDCl3):
δ 0.90–0.98 (m, 18H, CH2-CH3*), 1.00–1.03 (d, 36H, J = 8.1 Hz,
t-Bu), 1.18–1.22 (d, 36H, J = 12 Hz, t-Bu), 1.85–2.02 (m, 12H,
CH2*-CH3), 2.43–2.45 (d, 6H, J = 7.8 Hz, CH-CH3*), 3.16–3.2 (d,
6H, Ar-CH2-Ar), 3.27–3.32 (d, 2H, Ar-CH2-Ar), 3.72–3.95 (m, 12H,
OCH2), 3.96–4.0 (d, 2H, Ar-CH2-Ar), 4.30–4.34 (d, 2H, Ar-CH2-Ar),
4.47–4.55 (dd, 4H, Ar-CH2-Ar), 5.7–5.8 (q, 2H, J = 7.8 Hz,
CH*-CH3), 6.74 (s, 8H, ArH), 6.96 (s, 8H, ArH) and 8.36 ppm (s,
2H, ArH). 13C NMR (CDCl3): δ 10.06, 10.12, 10.24, 15.71, 23, 23.09,
23.12, 30.54, 30.72, 31.2, 31.31, 31.35, 31.42, 31.6, 33.8, 33.93, 34.08,
50.06, 77.21, 77.54, 118.46, 124.89, 125.06, 125.18, 125.32, 125.43,
132.4, 132.7, 133.39, 133.5, 134.04, 134.1, 134.51, 137.26, 143.73,
144.48, 144.52, 144.57, 147.53, 152.46, 155.76, 169.95 and 170 ppm.
C122H156N2O14 (1873.16): calcd. C 78.17, H 8.39, N 1.49 %; found
C 78.47, H 8.44, N 1.47 %.
3.4.6. (5c)
Yield: 53% (0.89 g). Compound 5c decomposes above 309 °C so
the melting point was not recorded. IR (KBr): ν = 2961, 2875,
1728, 1480, 1259 and 1198 cm–1. 1H NMR (CDCl3): δ 0.74–0.79 (t,
12H, J1 = 7.5 Hz, J2 = 7.2 Hz, CH2-CH3*), 1.0–1.03 (m, 6H,
CH2-CH3*), 1.06 (s, 36H, t-Bu), 1.19–1.2 (d, 36H, J = 3.3 Hz, t-Bu),
1.6–1.72 (m, 8H, CH2*-CH3), 1.97–2.05 (m, 4H, CH2*-CH3),
3.16–3.21 (d, 4H, Ar-CH2-Ar), 3.27–3.31 (d, 4H, Ar-CH2-Ar),
3.70–3.85 (m, 8H, OCH2), 3.96–4.04 (m, 4H, OCH2), 4.22–4.26 (d,
4H, Ar-CH2-Ar), 4.51–4.55 (d, 4H, Ar-CH2-Ar), 6.86 (s, 8H, ArH),
6.94 (s, 4H, ArH), 7.04 (s, 4H, ArH) and 8.93 ppm (s, 4H, com-
pound 4c). 13C NMR (CDCl3): δ 10.15, 22.95, 23.06, 30.97, 31.01,
31.37, 31.47, 31.57, 33.85, 33.92, 34.1, 77.15, 77.27, 124.96, 125.07,
125.52, 131, 133.16, 133.86, 134.18, 134.25, 143.79, 144.53, 144.61,
147.26, 152.44, 153.63 and 166.38 ppm. C114H150O10 (1679.12): calcd.
C 81.48, H 9.00 %; found C 81.59, H 8.93 %.
3.4.7. (5d)
Yield: 56% (0.93 g). Compound 5d decomposes above 314 °C so
the melting point was not recorded. IR (KBr): ν = 2962, 2874,
1751, 1481, 1198 and 1129 cm–1. 1H NMR (CDCl3): δ 0.85 (s, 36H,
t-Bu), 0.95-1 (t, 6H, J = 7.2 Hz, CH2-CH3*), 1.05–1.1 (t, 12H, J =
7.5 Hz, CH2-CH3*), 1.35–1.37 (d, 36H, J = 6.3 Hz, t-Bu), 1.88–2.06
(m, 16H, CH2*-CH3 and compound 4d), 3.17–3.23 (dd, 8H,
Ar-CH2-Ar), 3.6–3.7 (m, 8H, OCH2), 3.73–3.78 (m, 4H, OCH2),
4.07–4.11 (d, 4H, Ar-CH2-Ar), 4.13–4.16 (m, 4H, CH2-C=O),
4.53–4.57 (d, 4H, Ar-CH2-Ar), 6.49–6.50 (d, 4H, ArH), 6.59–6.60 (d,
4H, ArH) and 7.16–7.18 ppm (d, 8H, ArH). 13C NMR (CDCl3):
δ 9.8, 10.77, 22.96, 23.58, 24.56, 25.35, 30.72, 30.95, 31.12, 31.15,
31.63, 31.78, 33.63, 34.06, 34.23, 50.89, 77.25, 77.84, 124.78, 124.82,
125.08, 125.43, 131.48, 132.24, 135, 135.43, 144.36, 144.68, 147.38,
151.95, 154.62 and 174.48 ppm. C112H154O10 (1659.15): calcd.
C 81.02, H 9.35 %; found C 80.93, H 9.24 %.
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